AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology...

The Press of Atlantic City

Oct 9, 2019

SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ -- AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal dise…